Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea
Public ClinicalTrials.gov record NCT04106726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY, COMPARING IVERMECTIN CREAM 1% (ZYDUS WORLDWIDE DMCC) TO SOOLANTRA® (GALDERMA LABORATORIES, L.P.) AND BOTH ACTIVE TREATMENTS TO A PLACEBO CONTROL IN THE TREATMENT OF MODERATE TO SEVERE FACIAL ROSACEA
Study identification
- NCT ID
- NCT04106726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Zydus Worldwide DMCC
- Industry
- Enrollment
- 525 participants
Conditions and interventions
Conditions
Interventions
- Soolantra® Ivermectin cream 1% Drug
- Ivermectin cream 1% Drug
- Placebo for Ivermectin cream 1% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2019
- Primary completion
- Aug 3, 2020
- Completion
- Aug 3, 2020
- Last update posted
- Oct 13, 2020
2019 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zydus Worldwide DMCC | Brandon | Florida | 33511 | — |
| Zydus Worldwide DMCC | Fort Lauderdale | Florida | 33308 | — |
| Zydus Worldwide DMCC | Miami | Florida | 33175 | — |
| Zydus Worldwide DMCC | Miramar | Florida | 33027 | — |
| Zydus Worldwide DMCC | Tampa | Florida | 33609 | — |
| Zydus Worldwide DMCC | Saginaw | Michigan | 48604 | — |
| Zydus Worldwide DMCC | High Point | North Carolina | 27262 | — |
| Zydus Worldwide DMCC | Sugarloaf | Pennsylvania | 18249 | — |
| Zydus Worldwide DMCC | Upper Saint Clair | Pennsylvania | 15241 | — |
| Zydus Worldwide DMCC | El Paso | Texas | 79902 | — |
| Zydus Worldwide DMCC | El Paso | Texas | 79925 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04106726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04106726 live on ClinicalTrials.gov.